STAT3 inhibition was further shown to induce upregulation of several intracellular signaling molecules that are involved in T-cell and monocyte activation and may be used to promote CD4 and CD8 T cell-mediated tumor elimination [63]. The gene discussed is CD4; the disease is neoplasm.